King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recs

0
Player Avatar tnlbohrer (56.88) Submitted: 5/2/2008 10:45:04 AM : Outperform Start Price: $9.74 KG Score: +49.36

Buying low. Good Company with a wide variety of products.

Featured Broker Partners


Advertisement